Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathway.
Sun X, Zhang J, Liu H, Li M, Liu L, Yang Z, Hu W, Bai H, Xu J, Xing J, Xu Z, Mo A, Guo Z, Bai Y, Zhou Q, Wang Y, Zhang S, Zhang S.
Sun X, et al. Among authors: zhang s, zhang j.
Oncol Lett. 2023 May 23;26(1):295. doi: 10.3892/ol.2023.13881. eCollection 2023 Jul.
Oncol Lett. 2023.
PMID: 37274468
Free PMC article.